GlassScriptPhysician profile
Jill Swinning
NPI 1902161128
$10,147.65
in general payments reported to CMS, 2019-2025
7 companies · $813 in 2025
The $813 reported for 2025 was more than what 81% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $732 · 2022: $3,174 · 2023: $2,063 · 2024: $3,366 · 2025: $813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,229 · Food and Beverage: $1,036 · Travel and Lodging: $896 · Education: $81.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,228.75 |
| Food and Beverage | $1,036.19 |
| Travel and Lodging | $895.53 |
| Education | $81.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,226.07 | 2021-2025 | General - Therapies, Sq-Rx Pulse Generator |
| Medtronic, INC. | $3,384.00 | 2021-2024 | Linq II, Azure Xt Dr Mri Surescan, Selectsecure |
| Abbott Laboratories | $262.57 | 2021-2023 | Jot Dx, Ensite Precision, Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $161.54 | 2023-2024 | Lifevest |
| Biosense Webster, INC. | $62.18 | 2023 | Carto 3 |
| Janssen Pharmaceuticals, INC | $37.03 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $14.26 | 2024 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Swinning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.